Marks Group Wealth Management Inc Acquires 223 Shares of Danaher Co. (NYSE:DHR)

Marks Group Wealth Management Inc lifted its holdings in shares of Danaher Co. (NYSE:DHR) by 5.0% during the 3rd quarter, Holdings Channel reports. The firm owned 4,660 shares of the conglomerate’s stock after purchasing an additional 223 shares during the quarter. Marks Group Wealth Management Inc’s holdings in Danaher were worth $1,296,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Balentine LLC acquired a new stake in Danaher in the third quarter worth $420,000. Crestwood Advisors Group LLC boosted its position in shares of Danaher by 0.4% during the 3rd quarter. Crestwood Advisors Group LLC now owns 333,248 shares of the conglomerate’s stock worth $92,649,000 after purchasing an additional 1,264 shares in the last quarter. Pittenger & Anderson Inc. grew its stake in shares of Danaher by 3.2% in the 3rd quarter. Pittenger & Anderson Inc. now owns 67,823 shares of the conglomerate’s stock valued at $18,856,000 after buying an additional 2,116 shares during the period. Sentry Investment Management LLC increased its position in Danaher by 65.6% in the 3rd quarter. Sentry Investment Management LLC now owns 3,086 shares of the conglomerate’s stock valued at $858,000 after buying an additional 1,223 shares in the last quarter. Finally, United Advisor Group LLC acquired a new position in Danaher during the 3rd quarter worth approximately $230,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on DHR. Evercore ISI boosted their price objective on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. StockNews.com upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Wednesday. KeyCorp lifted their price objective on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Raymond James lowered their target price on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Finally, Robert W. Baird cut their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Insider Buying and Selling at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 10.90% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $247.81 on Thursday. Danaher Co. has a fifty-two week low of $192.35 and a fifty-two week high of $281.70. The company’s 50-day moving average is $265.79 and its 200 day moving average is $260.75. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company has a market capitalization of $178.99 billion, a P/E ratio of 47.29, a price-to-earnings-growth ratio of 4.55 and a beta of 0.85.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same quarter last year, the business posted $2.02 EPS. Danaher’s quarterly revenue was up 3.1% compared to the same quarter last year. On average, equities research analysts forecast that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is currently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.